Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

AstraZeneca Withdraws Covid-19 Vaccine, Citing Lack of Demand

AstraZeneca Plc pulled its Covid-19 vaccine from the market due to lack of demand for a shot that initially raised…

Zulassung für Impfstoff von AstraZeneca zurückgezogen

In der Europäischen Union ist der Corona-Impfstoff von AstraZeneca nicht mehr zugelassen – das habe „kommerzielle Gründe“, sagt das schwedisch-britische…

Warum der Impfstoff Vaxzevria in der EU nicht mehr zugelassen ist

Seit heute ist der Corona-Impfstoff von AstraZeneca in der EU nicht mehr zugelassen. In den sozialen Medien werden Bedenken bei…

Amgen, newer rivals could threaten Novo Nordisk and Eli Lillys weight loss drug dominance

Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments.…

AstraZeneca concludes equity investment in Cellectis

AstraZeneca has concluded an equity investment in clinical-stage biotechnology company Cellectis following a deal signed in November 2023.…

AstraZeneca completes Cellectis equity investment

7 May 2024 AstraZeneca completes equity investment agreement with Cellectis AstraZeneca today announced the successful completion of an equity investment with Cellectis,…

The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes

AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes are included in this Analyst Blog.…

ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant

…

ANGLE inks £550,000 deal with AstraZeneca for prostate cancer detection, shares jump

ANGLE plc, the AIM-listed liquid biopsy company, has inked a major supplier agreement with pharmaceutical giant AstraZeneca. The £550,000 deal…

ANGLE teams up with AstraZeneca on a second assay

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), a leader in liquid biopsy technology, has signed a supplier agreement with AstraZeneca PLC (LSE:AZN) to…

dpa-AFX ProFeed